Does AMBRISENTAN Cause Central venous catheterisation? 263 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 263 reports of Central venous catheterisation have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.3% of all adverse event reports for AMBRISENTAN.
263
Reports of Central venous catheterisation with AMBRISENTAN
0.3%
of all AMBRISENTAN reports
10
Deaths
189
Hospitalizations
How Dangerous Is Central venous catheterisation From AMBRISENTAN?
Of the 263 reports, 10 (3.8%) resulted in death, 189 (71.9%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 263 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
GLYCINE\MANNITOL\SODIUM (56)
Which AMBRISENTAN Alternatives Have Lower Central venous catheterisation Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE